|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care显示文摘 | Katharine Bushby Richard Finkel David J Birnkrant Laura E Case Paula R Clemens Linda Cripe Ajay Kaul Kathi Kinnett Craig McDonald Shree Pandya James Poysky Frederic Shapiro Jean Tomezsko Carolyn Constantin | 2010 | Lancet Neurology2010，，2： | 1 |
| 2 | Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant D J | 2010 | Lancet Neurol2010，9，1： | 1 |
| 3 | The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza显示文摘 | Birnkrant D Cox E | 2009 | NEJM2009，361，23： | 1 |
| 4 | Diagnosis and management of Duchenne muscular dystrophy, part 1 : diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant DJ | 2010 | Lancet Neuro12010，9，1： | 1 |
| 5 | Use of ribavirin to treat influenza显示文摘 | Chan-Tack K Murray J Birnkrant D | 2009 | NEJM2009，361，17： | 1 |
| 6 | Diagnosis and management of Duchenne muscular dystrophy,part 1:diagnosis,and pharmacological and psychosocial management显示文摘 | Bushby K Finkel R Birnkrant DJ | | 0，，： | 1 |
| 7 | Childhood herpes zoster显示文摘 | Papadopolos AJ Birnkrant AP Schwartz RA | 2001 | Pediatr Dermatol2001，68，1： | 1 |
| 8 | Intracranial hemor- rhage and liver-associated deaths associated with tipranavir/riton- avir: review of cases from the FDA's Adverse Event Reporting Sys- tem显示文摘 | Chan-Tack KM Struble KA Birnkrant DB | 2008 | AIDS Patient Care STDS2008，22，11： | 1 |
| 9 | Diagnosis and management of Duchenne muscular dystrophy, part 1 : diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant DJ | 2010 | Lancet Neurol2010，9，： | 1 |
| 10 | Respiratory care of the patient with Duehenne muscular dystrophy: ATS consensus statement显示文摘 | Finder JD Birnkrant D Carl J | 2004 | Am J Respir Crit Care Med2004，170，： | 1 |
| 11 | Diagnosis and management of Duchenne muscular dystrophy, part 1 : diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant DJ | 2010 | Lancet Neurol2010，9，： | 1 |
| 12 | Dia~aosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant DJ | 2010 | Lancet Neurol2010，9，1： | 1 |
| 13 | The assessment and management of the respiratory complications of pediatric neuromuscular diseases 显示文摘 | Birnkrant DJ | 2002 | Clin Pediatr ( Phila)2002，41，： | 1 |
| 14 | Diagnosis and management of Duchenne muscular dystrophy,part 1:diagnosis,and pharmacological and psychosocial management显示文摘 | Bushby K Finkel R Birnkrant DJ | 2010 | Lancet Neurol2010，9，1： | 1 |
| 15 | Diagnosis and management of Duchenne muscular dystrophy, Part 1: diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant D J | 2010 | Lancet Neurol2010，9，1： | 1 |
| 16 | Diagnosis and management of Duchenne muscular dystrophy, part 1 : diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant DJ | 2010 | Lancet Neurol2010，9，： | 1 |
| 17 | Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States显示文摘 | Kuei-Meng Wu Hanan Ghantous Debra B. Birnkrant | 2008 | Food and Chemical Toxicology2008，，8： | 1 |
| 18 | Use of ribavirin to treat influenza 显示文摘 | Chan-Tack KM Murray JS Birnkrant DB | 2009 | N Engl J Med2009，361，： | 1 |
| 19 | Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States显示文摘 | WU KM GHANTOUS H BIRNKRANT DB | 2008 | Food Chem Toxicol2008，46，8： | 1 |
| 20 | Diagnosis and manage- ment of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management 显示文摘 | Bushby K Finkel R Birnkrant DJ | 2010 | Lancet Neu- rol2010，9，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员